Payer

Some health insurers are cracking down on off-label prescriptions of new weight loss drugs such as Ozempic, The Washington Post reported June 12.

CMS' proposed rules to improve drug price transparency in Medicaid is a "positive step" toward controlling costs, Kate McEvoy, executive director of the National Association of Medicaid Directors, told Becker's. 

A top Centene executive plans to retire next year, and the company is divesting its non-core businesses. 

The Biden administration has reached a tentative deal that would preserve a provision of the ACA requiring insurers to cover preventive services while a Texas judge's ruling against the mandate is appealed in court.

From rolling back a planned gastroenterology endoscopy prior authorization policy to making an unsolicited cash offer to acquire Amedisys, here are 10 updates on UnitedHealth Group Becker's has reported since May 22.    

New GLP-1 drugs to treat diabetes and obesity can be expensive, and most payers do not cover drugs only for weight loss for their members. 

JPMorgan's health arm, Morgan Health, has published a policy guide for federal lawmakers that aims to advance and scale value-based care models within employer-based health insurance.

Independence Blue Cross' Keystone Health Plan East received an estimated $11.3 million in overpayments for 2016 and 2017, according to an audit from HHS' Office of Inspector General. 

New York City's comptroller is halting implementation of an Aetna Medicare Advantage plan for retired city employees while the contract is challenged in court. 

Unlike other large payers, individual Blue Cross Blue Shield companies are not publicly traded, making it difficult to find public executive compensation figures.